Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides
Rheumatoid arthritis (RA) is an inflammatory autoimmune disease affecting about 0.24 % of the world population. Protein arginine deiminase type 4 (PAD4) is believed to be responsible for the occurrence of RA by catalyzing citrullination of proteins. The citrullinated proteins act as autoantigens by...
Saved in:
Main Authors: | Ahmad Nadzirin, Izzuddin, Leow, Adam Thean Chor, Salleh, Abu Bakar, Abdul Rahman, Mohd Basyaruddin, Tejo, Bimo Ario |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/96755/1/ABSTRACT.pdf http://psasir.upm.edu.my/id/eprint/96755/ https://www.sciencedirect.com/science/article/pii/S1476927121000542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of new inhibitor for the Protein Arginine Deiminase Type 4 (PAD4) by Rational Design of α-Enolase-derived Peptides
by: Ahmad Nadzirin, Izzuddin, et al.
Published: (2021) -
Ligand-based virtual screening for the discovery of inhibitors for protein arginine deiminase type 4 (PAD4)
by: Teo, Chian Ying, et al.
Published: (2013) -
Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4)
by: Teo, Chian Ying, et al.
Published: (2017) -
Structure-based design of peptide inhibitors for Protein Arginine Deiminase Type IV (PAD4)
by: Teo, Chian Ying, et al.
Published: (2018) -
In-silico identification of potential Protein Arginine Deiminase IV (PAD4) inhibitors
by: Ibrahim, Zalikha, et al.
Published: (2016)